Hector Gonzalez Garcia, MD
Gynecology · Annapolis, MDNPI 1528250073
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Terumo Medical Corporation at 50.7% of the total. 2025 is the largest year on record at $13,528, more than ten times the $225 reported in 2019. Among gynecology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $155.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$11K
- Boston Scientific$3K
- Abbott$3K
- Axonics, Inc.$1K
- Intuitive Surgical$1K
- Coloplast$707
- plus $2K from 24 others
What the payments were for
- Consulting fees$12,95057%
- Speaking & faculty fees$2,25010%
- Travel & lodging$2,90313%
- Food & beverage$4,38119%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 7 | $11,450 |
| Boston Scientific | 13 | $2,882 |
| Abbott | 2 | $2,500 |
| Axonics, Inc. | 25 | $1,482 |
| Intuitive Surgical | 4 | $1,125 |
| Coloplast | 7 | $707 |
| Sumitomo Pharma America, Inc. | 29 | $550 |
| Baxter Healthcare | 4 | $275 |
| Astellas Pharma US Inc | 8 | $254 |
| Urovant Sciences Inc | 7 | $181 |
| Caldera Medical, Inc | 1 | $146 |
| Bayer | 4 | $111 |
| Endo USA, Inc. | 4 | $104 |
| Teleflex LLC | 3 | $95 |
| Immunitybio, Inc. | 1 | $91 |
| Myovant Sciences Inc. | 3 | $90 |
| Valencia Technologies Corporation | 1 | $90 |
| Medtronic | 4 | $73 |
| Johnson & Johnson(2 entities) | 3 | $70 |
| Ferring Pharmaceuticals Inc. | 3 | $55 |
| AbbVie | 2 | $42 |
| Olympus America Inc. | 2 | $41 |
| Tolmar, Inc. | 1 | $30 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Urogen Pharma, Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Hollister Incorporated | 1 | $17 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| Sagent Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Heartrail$11,450
- DRAGONFLY OPSTAR$2,500
- AVVIGO Guidance System$1,250
- ACCOLADE SR$1,201
- Da Vinci Surgical System$1,075
- Axonics$837
- Bulkamid$450
- ALTIS$394
- SUPRIS$169
- Desara$146
- LithoVue$121
- GEMTESA$108
- TISSEEL$106
How this compares
$22,584 in reported general payments places this provider in the 90th percentile of 79 gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 232 | $221,165 |
| MyrbetriqMirabegron | 29 | $26,634 |
| Estradiol | 337 | $22,033 |
| EstringEstradiol | 12 | $6,185 |
| Methenamine Hippurate | 31 | $3,938 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 87 | $1,108 |
| Solifenacin Succinate | 16 | $618 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $328 |
| Cephalexin | 12 | $281 |
| Triamcinolone Acetonide | 13 | $54 |
| Ibuprofen | 28 | $52 |
| Ciprofloxacin Hcl | 12 | $49 |
| Tramadol Hcl | 31 | $42 |
| Gabapentin | 19 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $550 | $221,165232 claims |
| Astellas Pharma US IncMyrbetriq | $254 | $26,63429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 79 gynecology providers in Maryland.
Other gynecology in Annapolis
- Richard MarvelAnnapolis$40K
- Parabhdeep GillAnnapolis$7K
- Julia LubskyAnnapolis$4K
- Karen HardartAnnapolis$3K
- Lawrence PrichepAnnapolis$2K
- Debra Hardy CartwrightAnnapolis$493
- Vadim MorozovBaltimore$394K
- Andrew LondonLutherville$335K
- Ann PetersBaltimore$25K
- David ZisowForest Hill$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.